APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug-coated Balloon (DCB)

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Selected research

Market Outlook & Growth Opportunities

Global Drug-coated Balloon (DCB) Market Outlook and Growth Opportunities 2026

3 August 2026202 pages

Choose your research edition.

Industry ResearchDrug-coated Balloon (DCB) Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug-coated Balloon (DCB) Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Drug-coated Balloon (DCB) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug-coated Balloon (DCB) Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug-coated Balloon (DCB) Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

The global Drug-coated Balloon (DCB) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug-coated Balloon (DCB) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug-coated Balloon (DCB) market include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug-coated Balloon (DCB) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug-coated Balloon (DCB) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug-coated Balloon (DCB) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug-coated Balloon (DCB) market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug-coated Balloon (DCB) Segment by Company

Medtronic

Boston Scientific

Becton Dickinson

Biotronik

B. Braun

Philips

Abbott

Eurocor

Yinyi Biotech

Lepu Medical

Grand Pharma

Acotec Scientific

Shenqi Medical

MicroPort

Zylox-Tonbridge Medical

Zhejiang Barty Medical

Drug-coated Balloon (DCB) Segment by Type

Coronary DCB

Peripheral DCB (FP)

Peripheral DCB (BTK)

Drug-coated Balloon (DCB) Segment by Application

Dialysis Access (AVF/AVG)

Femoropopliteal (FP)

Below-the-Knee (BTK)

Drug-coated Balloon (DCB) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug-coated Balloon (DCB) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Drug-coated Balloon (DCB) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug-coated Balloon (DCB) significant trends, drivers, influence factors in global and regions.

6. To analyze Drug-coated Balloon (DCB) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug-coated Balloon (DCB) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug-coated Balloon (DCB) industry.

Chapter 3: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Drug-coated Balloon (DCB) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Drug-coated Balloon (DCB) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug-coated Balloon (DCB) Industry Trends Table 2. Drug-coated Balloon (DCB) Industry Drivers Table 3. Drug-coated Balloon (DCB) Industry Opportunities and Challenges Table 4. Drug-coated Balloon (DCB) Industry Restraints Table 5. Global Drug-coated Balloon (DCB) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug-coated Balloon (DCB) Revenue Share by Company (2021-2026) Table 7. Global Drug-coated Balloon (DCB) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Drug-coated Balloon (DCB) Sales Volume Share by Company (2021-2026) Table 9. Global Drug-coated Balloon (DCB) Average Price (USD/unit) of Company (2021-2026) Table 10. Global Drug-coated Balloon (DCB) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Drug-coated Balloon (DCB) Key Company Manufacturing Base & Headquarters Table 12. Global Drug-coated Balloon (DCB) Company, Product Type & Application Table 13. Global Drug-coated Balloon (DCB) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug-coated Balloon (DCB) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Coronary DCB Table 18. Significant Companies of Peripheral DCB (FP) Table 19. Significant Companies of Peripheral DCB (BTK) Table 20. Global Drug-coated Balloon (DCB) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Drug-coated Balloon (DCB) Sales Volume by Type (2021-2026) & (k units) Table 22. Global Drug-coated Balloon (DCB) Sales Volume by Type (2027-2032) & (k units) Table 23. Global Drug-coated Balloon (DCB) Sales Volume Share by Type (2021-2026) Table 24. Global Drug-coated Balloon (DCB) Sales Volume Share by Type (2027-2032) Table 25. Global Drug-coated Balloon (DCB) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drug-coated Balloon (DCB) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Drug-coated Balloon (DCB) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Drug-coated Balloon (DCB) Sales Value Share by Type (2021-2026) Table 29. Global Drug-coated Balloon (DCB) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Dialysis Access (AVF/AVG) Table 31. Significant Companies of Femoropopliteal (FP) Table 32. Significant Companies of Below-the-Knee (BTK) Table 33. Global Drug-coated Balloon (DCB) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Drug-coated Balloon (DCB) Sales Volume by Application (2021-2026) & (k units) Table 35. Global Drug-coated Balloon (DCB) Sales Volume by Application (2027-2032) & (k units) Table 36. Global Drug-coated Balloon (DCB) Sales Volume Share by Application (2021-2026) Table 37. Global Drug-coated Balloon (DCB) Sales Volume Share by Application (2027-2032) Table 38. Global Drug-coated Balloon (DCB) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Drug-coated Balloon (DCB) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Drug-coated Balloon (DCB) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Drug-coated Balloon (DCB) Sales Value Share by Application (2021-2026) Table 42. Global Drug-coated Balloon (DCB) Sales Value Share by Application (2027-2032) Table 43. Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Drug-coated Balloon (DCB) Sales by Region (2021-2026) & (k units) Table 45. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2021-2026) Table 46. Global Drug-coated Balloon (DCB) Sales by Region (2027-2032) & (k units) Table 47. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2027-2032) Table 48. Global Drug-coated Balloon (DCB) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Drug-coated Balloon (DCB) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Drug-coated Balloon (DCB) Sales Value Share by Region (2021-2026) Table 51. Global Drug-coated Balloon (DCB) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Drug-coated Balloon (DCB) Sales Value Share by Region (2027-2032) Table 53. Global Drug-coated Balloon (DCB) Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Drug-coated Balloon (DCB) Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Drug-coated Balloon (DCB) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Drug-coated Balloon (DCB) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 58. Global Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2026) Table 59. Global Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 60. Global Drug-coated Balloon (DCB) Sales Market Share by Country (2027-2032) Table 61. Global Drug-coated Balloon (DCB) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Drug-coated Balloon (DCB) Sales Value Market Share by Country (2021-2026) Table 63. Global Drug-coated Balloon (DCB) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Drug-coated Balloon (DCB) Sales Value Market Share by Country (2027-2032) Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Medtronic Drug-coated Balloon (DCB) Product Portfolio Table 69. Medtronic Recent Development Table 70. Boston Scientific Company Information Table 71. Boston Scientific Business Overview Table 72. Boston Scientific Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Boston Scientific Drug-coated Balloon (DCB) Product Portfolio Table 74. Boston Scientific Recent Development Table 75. Becton Dickinson Company Information Table 76. Becton Dickinson Business Overview Table 77. Becton Dickinson Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio Table 79. Becton Dickinson Recent Development Table 80. Biotronik Company Information Table 81. Biotronik Business Overview Table 82. Biotronik Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Biotronik Drug-coated Balloon (DCB) Product Portfolio Table 84. Biotronik Recent Development Table 85. B. Braun Company Information Table 86. B. Braun Business Overview Table 87. B. Braun Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. B. Braun Drug-coated Balloon (DCB) Product Portfolio Table 89. B. Braun Recent Development Table 90. Philips Company Information Table 91. Philips Business Overview Table 92. Philips Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Philips Drug-coated Balloon (DCB) Product Portfolio Table 94. Philips Recent Development Table 95. Abbott Company Information Table 96. Abbott Business Overview Table 97. Abbott Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Abbott Drug-coated Balloon (DCB) Product Portfolio Table 99. Abbott Recent Development Table 100. Eurocor Company Information Table 101. Eurocor Business Overview Table 102. Eurocor Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Eurocor Drug-coated Balloon (DCB) Product Portfolio Table 104. Eurocor Recent Development Table 105. Yinyi Biotech Company Information Table 106. Yinyi Biotech Business Overview Table 107. Yinyi Biotech Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio Table 109. Yinyi Biotech Recent Development Table 110. Lepu Medical Company Information Table 111. Lepu Medical Business Overview Table 112. Lepu Medical Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Lepu Medical Drug-coated Balloon (DCB) Product Portfolio Table 114. Lepu Medical Recent Development Table 115. Grand Pharma Company Information Table 116. Grand Pharma Business Overview Table 117. Grand Pharma Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Grand Pharma Drug-coated Balloon (DCB) Product Portfolio Table 119. Grand Pharma Recent Development Table 120. Acotec Scientific Company Information Table 121. Acotec Scientific Business Overview Table 122. Acotec Scientific Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio Table 124. Acotec Scientific Recent Development Table 125. Shenqi Medical Company Information Table 126. Shenqi Medical Business Overview Table 127. Shenqi Medical Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio Table 129. Shenqi Medical Recent Development Table 130. MicroPort Company Information Table 131. MicroPort Business Overview Table 132. MicroPort Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. MicroPort Drug-coated Balloon (DCB) Product Portfolio Table 134. MicroPort Recent Development Table 135. Zylox-Tonbridge Medical Company Information Table 136. Zylox-Tonbridge Medical Business Overview Table 137. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio Table 139. Zylox-Tonbridge Medical Recent Development Table 140. Zhejiang Barty Medical Company Information Table 141. Zhejiang Barty Medical Business Overview Table 142. Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio Table 144. Zhejiang Barty Medical Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Drug-coated Balloon (DCB) Distributors List Table 148. Drug-coated Balloon (DCB) Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Drug-coated Balloon (DCB) Product Image Figure 2. Global Drug-coated Balloon (DCB) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug-coated Balloon (DCB) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Drug-coated Balloon (DCB) Sales (2021-2032) & (k units) Figure 5. Global Drug-coated Balloon (DCB) Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Drug-coated Balloon (DCB) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Coronary DCB Image Figure 10. Peripheral DCB (FP) Image Figure 11. Peripheral DCB (BTK) Image Figure 12. Global Drug-coated Balloon (DCB) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Drug-coated Balloon (DCB) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Drug-coated Balloon (DCB) Sales Volume Share by Type (2021-2032) Figure 15. Global Drug-coated Balloon (DCB) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Drug-coated Balloon (DCB) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Drug-coated Balloon (DCB) Sales Value Share by Type (2021-2032) Figure 18. Dialysis Access (AVF/AVG) Image Figure 19. Femoropopliteal (FP) Image Figure 20. Below-the-Knee (BTK) Image Figure 21. Global Drug-coated Balloon (DCB) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Drug-coated Balloon (DCB) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Drug-coated Balloon (DCB) Sales Volume Share by Application (2021-2032) Figure 24. Global Drug-coated Balloon (DCB) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Drug-coated Balloon (DCB) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Drug-coated Balloon (DCB) Sales Value Share by Application (2021-2032) Figure 27. Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Drug-coated Balloon (DCB) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Drug-coated Balloon (DCB) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Drug-coated Balloon (DCB) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Drug-coated Balloon (DCB) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Drug-coated Balloon (DCB) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Drug-coated Balloon (DCB) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Drug-coated Balloon (DCB) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Drug-coated Balloon (DCB) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Drug-coated Balloon (DCB) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Drug-coated Balloon (DCB) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Drug-coated Balloon (DCB) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Drug-coated Balloon (DCB) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Drug-coated Balloon (DCB) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Drug-coated Balloon (DCB) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Drug-coated Balloon (DCB) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Coronary DCB
  • Peripheral DCB (FP)
  • Peripheral DCB (BTK)
Applications
  • Dialysis Access (AVF/AVG)
  • Femoropopliteal (FP)
  • Below-the-Knee (BTK)
Companies covered
  • Medtronic
  • Boston Scientific
  • Becton Dickinson
  • Biotronik
  • B. Braun
  • Philips
  • Abbott
  • Eurocor
  • Yinyi Biotech
  • Lepu Medical
  • Grand Pharma
  • Acotec Scientific
  • Shenqi Medical
  • MicroPort
  • Zylox-Tonbridge Medical
  • Zhejiang Barty Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drug-coated Balloon (DCB) Sales Value (2021-2032)
  4. 1.2.2 Global Drug-coated Balloon (DCB) Sales Volume (2021-2032)
  5. 1.2.3 Global Drug-coated Balloon (DCB) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Drug-coated Balloon (DCB) Market Dynamics
  1. 2.1 Drug-coated Balloon (DCB) Industry Trends
  2. 2.2 Drug-coated Balloon (DCB) Industry Drivers
  3. 2.3 Drug-coated Balloon (DCB) Industry Opportunities and Challenges
  4. 2.4 Drug-coated Balloon (DCB) Industry Restraints
3 Drug-coated Balloon (DCB) Market by Company
  1. 3.1 Global Drug-coated Balloon (DCB) Company Revenue Ranking in 2025
  2. 3.2 Global Drug-coated Balloon (DCB) Revenue by Company (2021-2026)
  3. 3.3 Global Drug-coated Balloon (DCB) Sales Volume by Company (2021-2026)
  4. 3.4 Global Drug-coated Balloon (DCB) Average Price by Company (2021-2026)
  5. 3.5 Global Drug-coated Balloon (DCB) Company Ranking (2024-2026)
  6. 3.6 Global Drug-coated Balloon (DCB) Company Manufacturing Base and Headquarters
  7. 3.7 Global Drug-coated Balloon (DCB) Company Product Type and Application
  8. 3.8 Global Drug-coated Balloon (DCB) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Drug-coated Balloon (DCB) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Drug-coated Balloon (DCB) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Drug-coated Balloon (DCB) Market by Type
  1. 4.1 Drug-coated Balloon (DCB) Type Introduction
  2. 4.1.1 Coronary DCB
  3. 4.1.2 Peripheral DCB (FP)
  4. 4.1.3 Peripheral DCB (BTK)
  5. 4.2 Global Drug-coated Balloon (DCB) Sales Volume by Type
  6. 4.2.1 Global Drug-coated Balloon (DCB) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drug-coated Balloon (DCB) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Drug-coated Balloon (DCB) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Drug-coated Balloon (DCB) Sales Value by Type
  10. 4.3.1 Global Drug-coated Balloon (DCB) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Drug-coated Balloon (DCB) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Drug-coated Balloon (DCB) Sales Value Share by Type (2021-2032)
5 Drug-coated Balloon (DCB) Market by Application
  1. 5.1 Drug-coated Balloon (DCB) Application Introduction
  2. 5.1.1 Dialysis Access (AVF/AVG)
  3. 5.1.2 Femoropopliteal (FP)
  4. 5.1.3 Below-the-Knee (BTK)
  5. 5.2 Global Drug-coated Balloon (DCB) Sales Volume by Application
  6. 5.2.1 Global Drug-coated Balloon (DCB) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug-coated Balloon (DCB) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Drug-coated Balloon (DCB) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Drug-coated Balloon (DCB) Sales Value by Application
  10. 5.3.1 Global Drug-coated Balloon (DCB) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drug-coated Balloon (DCB) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Drug-coated Balloon (DCB) Sales Value Share by Application (2021-2032)
6 Drug-coated Balloon (DCB) Regional Sales and Value Analysis
  1. 6.1 Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug-coated Balloon (DCB) Sales by Region (2021-2032)
  3. 6.2.1 Global Drug-coated Balloon (DCB) Sales by Region: 2021-2026
  4. 6.2.2 Global Drug-coated Balloon (DCB) Sales by Region (2027-2032)
  5. 6.3 Global Drug-coated Balloon (DCB) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Drug-coated Balloon (DCB) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Drug-coated Balloon (DCB) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Drug-coated Balloon (DCB) Sales Value by Region (2027-2032)
  9. 6.5 Global Drug-coated Balloon (DCB) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Drug-coated Balloon (DCB) Sales Value (2021-2032)
  12. 6.6.2 North America Drug-coated Balloon (DCB) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Drug-coated Balloon (DCB) Sales Value (2021-2032)
  15. 6.7.2 Europe Drug-coated Balloon (DCB) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Drug-coated Balloon (DCB) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Drug-coated Balloon (DCB) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Drug-coated Balloon (DCB) Sales Value (2021-2032)
  21. 6.9.2 South America Drug-coated Balloon (DCB) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Drug-coated Balloon (DCB) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Drug-coated Balloon (DCB) Sales Value Share by Country, 2025 VS 2032
7 Drug-coated Balloon (DCB) Country-level Sales and Value Analysis
  1. 7.1 Global Drug-coated Balloon (DCB) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug-coated Balloon (DCB) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Drug-coated Balloon (DCB) Sales by Country (2021-2032)
  4. 7.3.1 Global Drug-coated Balloon (DCB) Sales by Country (2021-2026)
  5. 7.3.2 Global Drug-coated Balloon (DCB) Sales by Country (2027-2032)
  6. 7.4 Global Drug-coated Balloon (DCB) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Drug-coated Balloon (DCB) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Drug-coated Balloon (DCB) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Drug-coated Balloon (DCB) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Drug-coated Balloon (DCB) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Drug-coated Balloon (DCB) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Drug-coated Balloon (DCB) Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Becton Dickinson
  14. 8.3.1 Becton Dickinson Company Information
  15. 8.3.2 Becton Dickinson Business Overview
  16. 8.3.3 Becton Dickinson Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
  18. 8.3.5 Becton Dickinson Recent Developments
  19. 8.4 Biotronik
  20. 8.4.1 Biotronik Company Information
  21. 8.4.2 Biotronik Business Overview
  22. 8.4.3 Biotronik Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Biotronik Drug-coated Balloon (DCB) Product Portfolio
  24. 8.4.5 Biotronik Recent Developments
  25. 8.5 B. Braun
  26. 8.5.1 B. Braun Company Information
  27. 8.5.2 B. Braun Business Overview
  28. 8.5.3 B. Braun Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 B. Braun Drug-coated Balloon (DCB) Product Portfolio
  30. 8.5.5 B. Braun Recent Developments
  31. 8.6 Philips
  32. 8.6.1 Philips Company Information
  33. 8.6.2 Philips Business Overview
  34. 8.6.3 Philips Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Philips Drug-coated Balloon (DCB) Product Portfolio
  36. 8.6.5 Philips Recent Developments
  37. 8.7 Abbott
  38. 8.7.1 Abbott Company Information
  39. 8.7.2 Abbott Business Overview
  40. 8.7.3 Abbott Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abbott Drug-coated Balloon (DCB) Product Portfolio
  42. 8.7.5 Abbott Recent Developments
  43. 8.8 Eurocor
  44. 8.8.1 Eurocor Company Information
  45. 8.8.2 Eurocor Business Overview
  46. 8.8.3 Eurocor Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Eurocor Drug-coated Balloon (DCB) Product Portfolio
  48. 8.8.5 Eurocor Recent Developments
  49. 8.9 Yinyi Biotech
  50. 8.9.1 Yinyi Biotech Company Information
  51. 8.9.2 Yinyi Biotech Business Overview
  52. 8.9.3 Yinyi Biotech Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
  54. 8.9.5 Yinyi Biotech Recent Developments
  55. 8.10 Lepu Medical
  56. 8.10.1 Lepu Medical Company Information
  57. 8.10.2 Lepu Medical Business Overview
  58. 8.10.3 Lepu Medical Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
  60. 8.10.5 Lepu Medical Recent Developments
  61. 8.11 Grand Pharma
  62. 8.11.1 Grand Pharma Company Information
  63. 8.11.2 Grand Pharma Business Overview
  64. 8.11.3 Grand Pharma Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
  66. 8.11.5 Grand Pharma Recent Developments
  67. 8.12 Acotec Scientific
  68. 8.12.1 Acotec Scientific Company Information
  69. 8.12.2 Acotec Scientific Business Overview
  70. 8.12.3 Acotec Scientific Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
  72. 8.12.5 Acotec Scientific Recent Developments
  73. 8.13 Shenqi Medical
  74. 8.13.1 Shenqi Medical Company Information
  75. 8.13.2 Shenqi Medical Business Overview
  76. 8.13.3 Shenqi Medical Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
  78. 8.13.5 Shenqi Medical Recent Developments
  79. 8.14 MicroPort
  80. 8.14.1 MicroPort Company Information
  81. 8.14.2 MicroPort Business Overview
  82. 8.14.3 MicroPort Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 MicroPort Drug-coated Balloon (DCB) Product Portfolio
  84. 8.14.5 MicroPort Recent Developments
  85. 8.15 Zylox-Tonbridge Medical
  86. 8.15.1 Zylox-Tonbridge Medical Company Information
  87. 8.15.2 Zylox-Tonbridge Medical Business Overview
  88. 8.15.3 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
  90. 8.15.5 Zylox-Tonbridge Medical Recent Developments
  91. 8.16 Zhejiang Barty Medical
  92. 8.16.1 Zhejiang Barty Medical Company Information
  93. 8.16.2 Zhejiang Barty Medical Business Overview
  94. 8.16.3 Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
  96. 8.16.5 Zhejiang Barty Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug-coated Balloon (DCB) Value Chain Analysis
  2. 9.1.1 Drug-coated Balloon (DCB) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug-coated Balloon (DCB) Sales Mode & Process
  6. 9.2 Drug-coated Balloon (DCB) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug-coated Balloon (DCB) Distributors
  9. 9.2.3 Drug-coated Balloon (DCB) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst